Form D · Other Technology
Moxe Health Corp
Madison, WI · CIK 0001686302
Offering snapshot reported Jun 9, 2022 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 20, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 9, 2022 | Initial | $29,999,994 | No comparison | 4 | SEC filing |
| Oct 4, 2016 | Initial | $4,818,992 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-448601
Source: Form D, filed Jun 9, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael Arce | Executive |
| Michael Coyne | Director, Executive |
| Gary Kurtzman | Director |
| Gary J. Kurtzman, M.D. | Director |
| Christopher Lahoud | Director |
| Kirk Nielsen | Director |
| Thomas Schnettler | Director |
| Daniel Wilson | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
228 North Henry Street Suite 300
Madison, WI, 53703
Madison, WI, 53703